STING1 and cancer: Similar to previous findings in the pan-cancer cell line panel, multiple components of the innate immunity/STING pathway (including PRR, IFN signaling, MHC presentation, and PD-L1-mediated immune checkpoints) were identified as at least two-fold higher in Rh41R (FDR< 0.05) (Figure 10).